This is the second in a series of webinars that examines how risk assessments for new chemicals have been improperly altered to eliminate or minimize risk calculations, according to U.S. Environmental Protection Agency (EPA) scientists in recent whistleblower complaints filed by Public Employees for Environmental Responsibility (PEER) to Congress and the EPA’s Inspector General.

The whistleblowers’ disclosures have shed a brighter light than ever before on practices used in the new chemicals review process that undermine transparency and stymie public accountability; allow undue industry influence over EPA safety decisions; skew those decisions in industry’s favor and away from the public interest; undermine scientific integrity; and impose tremendous costs on local communities who are left to deal with the health and financial consequences of EPA’s decisions.